T3N0M0 GLOTTIC CANCER - ARE MORE TREATMENT MODALITIES NECESSARILY BETTER

被引:4
|
作者
LARAMORE, GE
机构
关键词
D O I
10.1016/0360-3016(94)00583-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:423 / 425
页数:3
相关论文
共 50 条
  • [21] T3N0M0 NSCLC Subtypes - A Signal for Disparate Outcomes after Surgery
    Ferrari-Light, Dana
    Kneuertz, Peter J.
    SEMINARS IN THORACIC AND CARDIOVASCULAR SURGERY, 2023, 35 (04) : 805 - 806
  • [22] Adjuvant therapy for pathological T3N0M0 esophageal squamous cell carcinoma
    Zhang, Xiaobin
    Yang, Yu
    Sun, Yifeng
    Ye, Bo
    Guo, Xufeng
    Mao, Teng
    Hua, Rong
    Li, Bin
    Gu, Haiyong
    Liu, Jun
    Li, Zhigang
    JOURNAL OF THORACIC DISEASE, 2019, 11 (06) : 2512 - 2522
  • [23] Impact of postoperative radiotherapy for T3N0M0 esophageal cancer patients: A population-based study
    Ge, Yizhi
    Yin, Li
    Tan, Mingdian
    Dai, Weixing
    Jiang, Yaqi
    Chen, Li
    He, Xia
    CLINICAL AND TRANSLATIONAL MEDICINE, 2020, 10 (03):
  • [24] Utility for Additional Axillary and/or Systemic Staging Evaluation in Clinical T3N0M0 Breast Cancer Patients
    Dimaano, Fallon
    Bensenhaver, Jessica
    Petersen, Lindsay
    ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (SUPPL 2) : S376 - S377
  • [25] PET/CT findings and dose distribution during radiotherapy in T1N0M0-T2N0M0 glottic cancer
    Okada, Yukinori
    Zama, Tatsuhiko
    Itonaga, Tomohiro
    Mikami, Ryuji
    Okubo, Mitsuru
    Sugahara, Shinji
    Kurooka, Masahiko
    Nakai, Motoki
    Abe, Koichiro
    Yoshimura, Mana
    Saito, Kazuhiro
    HELLENIC JOURNAL OF NUCLEAR MEDICINE, 2024, 27 (01) : 27 - 34
  • [26] A COMPARISON OF RADIOTHERAPY AND SURGERY AS PRIMARY-TREATMENT IN THE MANAGEMENT OF T(3)N(0)M(0) GLOTTIC TUMORS
    SIMPSON, D
    ROBERTSON, AG
    LAMONT, D
    JOURNAL OF LARYNGOLOGY AND OTOLOGY, 1993, 107 (10): : 912 - 915
  • [27] Differences in risk factors for mortality between T2N1M0 and T3N0M0 lobular breast cancer patients: a comparative study
    Xia, Longjie
    Qin, Chunxin
    Chen, Wei
    Chen, Kang
    FRONTIERS IN PHARMACOLOGY, 2025, 16
  • [28] Oncologic Outcomes of Patients with Resected T3N0M0 Non-small Cell Lung Cancer
    Marques, E.
    Kennedy, K.
    Nishimura, K.
    Giroux, D.
    Cilento, V.
    Fang, W.
    Ugalde, P.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S866 - S867
  • [29] Variations of polychemotherapy (PCT) and hyperfractionated irradiation for (HFI) locally advanced larynx cancer (T3N0M0)
    Zak, E
    Alferov, V
    Madjidov, MG
    ANNALS OF ONCOLOGY, 1998, 9 : 77 - 77
  • [30] Oncologic Outcomes of Patients With Resected T3N0M0 Non-small Cell Lung Cancer
    Marques, Edouard
    Kennedy, Kevin F.
    Giroux, Dorothy J.
    Cilento, Vanessa B.
    Nishimura, Katherine K.
    Fang, Wentao
    Figueroa, Paula Ugalde
    SEMINARS IN THORACIC AND CARDIOVASCULAR SURGERY, 2023, 35 (04) : 796 - 804